Bangalore: Polyclone Bioservices signed a memorandum of understanding (MoU) with JSS University, Mysore, for collaborative R&D in biological sciences. The MoU is intended to expedite R&D of new methods and technologies that can be implemented and aligned with Polyclone's missions as well as aimed at enhancing the quality of research and education at JSS University.

The two organizations have agreed to promote exchange and cooperation in all appropriate and agreed areas of research and also facilitate co-operation between the staff of both organizations. 

Both JSS University and Polyclone believe that this collaboration will contribute to more efficient resource utilization, avert or minimize duplication, and accelerate methods and technology advancement in various fields of biological sciences. The two organizations further believe that successful collaboration will leverage beneficial results via method and technology transfer, education, and training.

Mr Naveen Kulkarni, CEO, Polyclone, stated that, "Our experience in stem cell technologies and with recent partnership in nanotechnology applications in stem cell therapy with PSG's Institute of Advanced Studies is further strengthened by JSS University's addition. This is mainly due to the association of JSS Medical college that is actively fostering this relationship with Polyclone in the area of advanced application of stem cell therapy for better clinical outcome."

He further said that, "The significance of having a clinical partner will only help us get closer to patient understanding and bring innovations outside the lab and this partnership with JSS University is the key, with access to a facility of more than 1,500 beds can generate insights into patient care aspects across different disease cycles ranging from ophthalmology-to-oncology and critical care like wound healing."